Inhibitors of mTOR have already been investigated in lung cancer, with clear evidence of anticancer activity both as single agents and in combination with cytotoxic chemotherapy and radiation (Milton et al, 2007; Sarkaria et al, 2007; Mita et al, 2008). The gene discussed is MTOR; the disease is lung cancer.